retatrutide autoimmune for disease 🚀 may represent the next evolution in medical weight management by targeting three metabolic pathways simultaneously. While the results are exciting, proper medical supervision remains GLP-1 Drugs: For Triple Agonist Obesity Medication May

The packaging advertises a GLP-1 7-in-1 formula with sweeping health claims: appetite suppression, sugar regulation, cardiovascular benefits, intestinal health and anti-aging effects

Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury

In May 2025, Aon released the first phase of a US study of GLP-1 medications for diabetes and weight management

The goal isnt to frighten you, but to individualize your care so surgery is as safe and smooth as possible

For more information see .

Activation of the GLP-1 receptor (GLP-1R) by GLP-1 stimulates insulin release and inhibits glucagon secretion in a glucose-dependent manner ( 4 )